Search research articles
Contact Us
Filters
Showing results (11-20 of 143) with videos related to
Page
of 15
Sort By:
The American Journal of Medicine
|
July 24, 2017
The Reply
Megan E Barra, John Fanikos
Drugs
|
October 11, 2014
New oral anticoagulants for the treatment of venous thromboembolism: understanding differences and similarities
Paul P Dobesh, John Fanikos
Thrombosis Research
|
May 3, 2011
New antithrombotics: the impact on global health care
Charles E Mahan, John Fanikos
Journal of General Internal Medicine
|
August 10, 2018
Addressing the Lack of Competition in Generic Drugs to Improve Healthcare Quality and Safety
Karthik Sivashanker, John Fanikos, Allen Kachalia
Hematology/Oncology Clinics of North America
|
September 18, 2016
Regulatory Impact on Thrombosis Treatment, Prevention, and Anticoagulant Use
Robert Dannemiller, Tucker Ward, John Fanikos
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
December 8, 2009
Aligning pharmacy and health-system objectives to eliminate central-line-associated bacteremias
Alan Lyles, John Fanikos, Kay Jewell
Current Drug Safety
|
March 10, 2010
Technology utilization to prevent medication errors
Allison Forni, Hanh T Chu, John Fanikos
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
May 6, 2016
Reversal agents for use with direct and indirect anticoagulants
Maureen A Smythe, Toby Trujillo, John Fanikos
Therapeutic Advances in Hematology
|
April 5, 2013
Efficacy and safety of novel anticoagulants compared with established agents
Iwona Rybak, Michael Ehle, Leo Buckley, et al.
The New England Journal of Medicine
|
September 5, 2019
Heart and Lung Transplants from HCV-Infected Donors. Reply
Ann E Woolley, John Fanikos, Lindsey R Baden
Page
of 15
Search research articles
Search
Showing results (11-20 of 143) with videos related to
Sort By:
Page
of 15
The American Journal of Medicine
|
July 24, 2017
The Reply
Megan E Barra, John Fanikos
Drugs
|
October 11, 2014
New oral anticoagulants for the treatment of venous thromboembolism: understanding differences and similarities
Paul P Dobesh, John Fanikos
Thrombosis Research
|
May 3, 2011
New antithrombotics: the impact on global health care
Charles E Mahan, John Fanikos
Journal of General Internal Medicine
|
August 10, 2018
Addressing the Lack of Competition in Generic Drugs to Improve Healthcare Quality and Safety
Karthik Sivashanker, John Fanikos, Allen Kachalia
Hematology/Oncology Clinics of North America
|
September 18, 2016
Regulatory Impact on Thrombosis Treatment, Prevention, and Anticoagulant Use
Robert Dannemiller, Tucker Ward, John Fanikos
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
December 8, 2009
Aligning pharmacy and health-system objectives to eliminate central-line-associated bacteremias
Alan Lyles, John Fanikos, Kay Jewell
Current Drug Safety
|
March 10, 2010
Technology utilization to prevent medication errors
Allison Forni, Hanh T Chu, John Fanikos
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
May 6, 2016
Reversal agents for use with direct and indirect anticoagulants
Maureen A Smythe, Toby Trujillo, John Fanikos
Therapeutic Advances in Hematology
|
April 5, 2013
Efficacy and safety of novel anticoagulants compared with established agents
Iwona Rybak, Michael Ehle, Leo Buckley, et al.
The New England Journal of Medicine
|
September 5, 2019
Heart and Lung Transplants from HCV-Infected Donors. Reply
Ann E Woolley, John Fanikos, Lindsey R Baden
Page
of 15